Atlas Trials

Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.

Clinical trial NCT00227461 · UNKNOWN

Trial details

NCT number
NCT00227461
Sponsor
Kessler Foundation
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
AphasiaStroke
Start date
2005-09-01
Primary completion
2021-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.